The primary cause of obesity is excessive food intake
When used for weight loss, we need established guidelines and comprehensive care that support the whole patient
Conversely, a retrospective study with 981 patients with T2DM showed no difference in diabetic retinopathy progression between GLP-1 RAs and SGLT-2 inhibitors [94]
Warning Signs to Watch For What to Do Before Starting Treatment What to Do During Treatment Potential Benefits Beyond the Eye Practical Patient Questions Related Reading Diabetic Eye Disease: The Complete Patient Guide Diabetic Retinopathy Stages Diabetic Macular Edema Diabetes Control and Eye Health Why Your Endocrinologist Matters in Diabetic Eye Disease Key Learning Points GLP-1 receptor agonists are useful diabetes medicines, but patients with diabetic retinopathy should not ignore eye monitoring
Because dual incretin agonists improve metabolic dysfunction so effectively, pharmaceutical firms are heavily investing in label expansions and pipeline drugs, like emerging triple-incretin agonists
The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic drugs